Brown Brothers Harriman & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $75.4K | Buy |
|
|||||
|
2025
Q2 | $44.9K | Sell |
|
|||||
|
2025
Q1 | $60.7K | Buy |
|
|||||
|
2024
Q4 | $71.8K | Buy |
|
|||||
|
2024
Q3 | $26.4K | Buy |
|
|||||
|
2024
Q2 | $25.8K | Sell |
|
|||||
|
2024
Q1 | $59.6K | Hold |
|
|||||
|
2023
Q4 | $52K | Buy |
|
|||||
|
2023
Q3 | $24.5K | Sell |
|
|||||
|
2023
Q2 | $114K | Sell |
|
|||||
|
2023
Q1 | $1.94M | Buy |
|
|||||
|
2022
Q4 | $1.09M | Buy |
|
|||||
|
2022
Q3 | $782K | Buy |
|
|||||
|
2022
Q2 | $727K | Buy |
|
|||||
|
2022
Q1 | $881K | Buy |
|
|||||
|
2021
Q4 | $996 | Buy |
|
|||||
|
2021
Q3 | $1.06K | Buy |
|
|||||
|
2021
Q2 | $886 | Buy |
|
|||||
|
2021
Q1 | $26 | Sell |
|
|||||
|
2020
Q4 | $24K | Sell |
|
|||||
|
2020
Q3 | $34K | Buy |
|
|||||
|
2020
Q2 | $21K | Hold |
|
|||||
|
2020
Q1 | $15K | Buy |
|
|||||
|
2019
Q4 | $16K | Sell |
|
|||||
|
2019
Q3 | $213K | Hold |
|
|||||
|
2019
Q2 | $228K | Hold |
|
|||||
|
2019
Q1 | $234K | Buy |
|
|||||
|
2018
Q4 | $172K | Buy |
|
|||||
|
2018
Q3 | $202K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $11K | Buy |
|
|||||
|
2017
Q3 | $2K | Hold |
|
|||||
|
2017
Q2 | $2K | Hold |
|
|||||
|
2017
Q1 | $1K | Buy |
|